Factors influencing credentialing of interventionists in the CREST-2 trial

The Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) is a pair of randomized trials assessing the relative efficacy of carotid revascularization in the setting of intensive medical management (IMM) in patients with asymptomatic high-grade atherosclerotic stenosis. One of the trials assesses IMM with or without carotid artery stenting (CAS). Given the low risk of stroke in nonrevascularized patients receiving IMM, it is essential that there be low periprocedural risk of stroke for CAS if it is to show incremental benefit.

Source: Journal of Vascular Surgery - July 24, 2019 Category: Surgery Authors: Brajesh K. Lal, James F. Meschia, Gary S. Roubin, Brian Jankowitz, Donald Heck, Tudor Jovin, Christopher J. White, Kenneth Rosenfield, Barry Katzen, Guilherme Dabus, William Gray, Jon Matsumura, L. Nelson Hopkins, Sothear Luke, Jashank Sharma, Jenifer H. Source Type: research